T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Consumer Discretionary | 14.05% |
| 3 | Financials | 13.42% |
| 4 | Industrials | 12.52% |
| 5 | Technology | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADXS
1326
DELISTED
Advaxis Inc
ADXS
| $9.75M | ﹤0.01% |
+81,185
| New | +$4.56M |
|
|
ARRS
1327
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $9.67M | ﹤0.01% |
320,414
+281,500
| +723% | +$7.97M |
|
1328
Commercial Metals
CMC
$8.02B
| $9.64M | ﹤0.01% |
591,680
+276,830
| +88% | +$4.48M |
|
|
RLYP
1329
DELISTED
RELYPSA INC COM
RLYP
| $9.62M | ﹤0.01% |
312,389
+298,220
| +2,105% | +$7.1M |
|
|
WIN
1330
DELISTED
Windstream Holdings Inc
WIN
| $9.61M | ﹤0.01% |
148,908
-783,896
| -84% | -$59.9M |
|
|
BBNK
1331
DELISTED
BRIDGE CAPITAL HOLDINGS
BBNK
| $9.58M | ﹤0.01% |
428,161
+300
| +0.1% | +$6.95K |
|
|
ARAV
1332
DELISTED
Aravive, Inc. Common Stock
ARAV
| $9.58M | ﹤0.01% |
71,117
-1,050
| -1% | -$123K |
|
|
BLOX
1333
DELISTED
Infoblox Inc
BLOX
| $9.5M | ﹤0.01% |
470,270
-17,100
| -4% | -$286K |
|
|
ICON
1334
DELISTED
Iconix Brand Group, Inc.
ICON
| $9.44M | ﹤0.01% |
27,925
+570
| +2% | +$215K |
|
|
VTLE
1335
DELISTED
Vital Energy
VTLE
| $9.42M | ﹤0.01% |
45,491
-13,538
| -23% | -$4.1M |
|
1336
Allegion
ALLE
$14.1B
| $9.35M | ﹤0.01% |
168,628
+25,744
| +18% | +$1.34M |
|
|
AIV
1337
Aimco
AIV
$378M
| $9.35M | ﹤0.01% |
1,888,539
-150,061
| -7% | -$714K |
|
|
CTIC
1338
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.35M | ﹤0.01% |
+396,000
| New | +$9.16M |
|
|
TSS
1339
DELISTED
Total System Services, Inc.
TSS
| $9.23M | ﹤0.01% |
271,778
+13,500
| +5% | +$437K |
|
1340
Dick's Sporting Goods
DKS
$18.1B
| $9.19M | ﹤0.01% |
185,056
+1,192
| +0.6% | +$55.8K |
|
|
OTIC
1341
DELISTED
Otonomy, Inc.
OTIC
| $9.18M | ﹤0.01% |
275,412
-245,688
| -47% | -$6.58M |
|
1342
Walker & Dunlop
WD
$1.47B
| $9.13M | ﹤0.01% |
520,753
+5,300
| +1% | +$84.2K |
|
|
OPLN
1343
Openlane
OPLN
$4.38B
| $9.09M | ﹤0.01% |
693,319
-13,807
| -2% | -$167K |
|
1344
Warner Bros
WBD
$69.6B
| $9.04M | ﹤0.01% |
262,540
-1,152,277
| -81% | -$39.9M |
|
1345
FIVE9
FIVN
$2.44B
| $9.02M | ﹤0.01% |
2,013,840
+13,300
| +0.7% | +$61.9K |
|
1346
Leggett & Platt
LEG
$1.32B
| $9.02M | ﹤0.01% |
211,746
-190
| -0.1% | -$7.48K |
|
1347
Enerpac Tool Group
EPAC
$1.89B
| $8.87M | ﹤0.01% |
325,700
-68,200
| -17% | -$2.04M |
|
1348
Nasdaq
NDAQ
$54.2B
| $8.84M | ﹤0.01% |
553,200
+29,430
| +6% | +$433K |
|
|
BNCL
1349
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $8.82M | ﹤0.01% |
+791,114
| New | +$9.33M |
|
|
MTCN
1350
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $8.76M | ﹤0.01% |
506,419
+27
| +0% | +$522 |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.